Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/19/2024 | $3.00 → $4.00 | Neutral | Citigroup |
| 4/2/2024 | $5.00 → $1.50 | Buy → Underperform | BofA Securities |
| 12/19/2023 | $3.11 | Hold | Jefferies |
| 11/30/2023 | $8.00 → $3.00 | Outperform → Neutral | Robert W. Baird |
| 11/29/2023 | Overweight → Equal Weight | Wells Fargo | |
| 9/29/2023 | Peer Perform | Wolfe Research | |
| 8/25/2023 | $10.00 → $7.00 | Outperform | RBC Capital Mkts |
| 4/28/2023 | $10.00 | Hold | Gordon Haskett |
Q2 2024 Overview Net revenue of $1.52 billion decreased 0.5 percent year over year Comparable sales increased 0.3 percent year over year and increased 3.5 percent on a two-year basis GAAP net loss of $24.8 million, or $(0.09) per share, compared to GAAP net loss of $14.6 million, or $(0.05) per share in the prior yearAdjusted EBITDA1 of $83.5 million compared to $112.6 million in the prior yearOperating Cash Flow of $69.4 million compared to $96.6 million in the prior yearFree Cash Flow 1 of $42.0 million compared to $44.6 million in the prior yearSAN DIEGO, Sept. 10, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), a complete partner in pet health and wellness, to
SAN DIEGO, Aug. 1, 2024 /PRNewswire/ -- On September 10, 2024, at approximately 4:00 p.m. Eastern, Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, will release its second quarter 2024 earnings results. Additionally, Petco executives will host a conference call at approximately 5:00 p.m. Eastern to review the company's financial and operating performance. The call will be webcast live and the earnings release and earnings presentation will be available on the company's Investor Relations page at ir.petco.com. A replay of th
SAN DIEGO, July 30, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced that it has granted inducement equity awards on July 29, 2024 to its newly-hired Chief Executive Officer, Joel D. Anderson, as a material inducement to the employment of Mr. Anderson. The inducement awards consist of (i) 1,492,538 restricted stock units, (ii) 1,492,538 target performance stock units, (iii) non-qualified stock options to purchase 1,366,121 shares of Petco's Class A common stock with an exercise price of $5.00, and (iv) non-qualified stock options to pu
30-Year Retail Industry Veteran Named Chief Executive Officer and Member of the Board of Directors R. Michael Mohan to Lead a New Board Committee Focused on Value Creation SAN DIEGO, July 17, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced that the Company's Board of Directors has appointed Joel D. Anderson to serve as Chief Executive Officer (CEO), effective July 29, 2024. In addition, Anderson has been elected to serve on the Company's Board of Directors. "Joel is an inspirational leader and a highly experienced retail CEO," said Gl
Appoints James Roth as Chief Stores OfficerAppoints Shari White as Interim Chief Merchant SAN DIEGO, May 28, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced the evolution of the Executive Leadership Team as a part of the Company's ongoing efforts to simplify decision making, focus on fewer and clearer priorities, and empower the organization to move with greater speed and agility. "Today's changes to our leadership team will accelerate Petco's initiatives to drive retail excellence as we execute on our operational reset," said Interi
Murphy to support leadership team's initiatives to improve profitability and drive long-term growth SAN DIEGO, May 14, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced the appointment of Glenn Murphy as Executive Chairman of the Board of Directors, effective immediately. As Executive Chairman, Murphy will support the Petco leadership team's focus on improving profitability while implementing strategic actions to drive long-term growth. He will play a lead role in the Board of Directors' ongoing search for a permanent Chief Executive O
Citigroup reiterated coverage of Petco Health and Wellness with a rating of Neutral and set a new price target of $4.00 from $3.00 previously
BofA Securities downgraded Petco Health and Wellness from Buy to Underperform and set a new price target of $1.50 from $5.00 previously
Jefferies initiated coverage of Petco Health and Wellness with a rating of Hold and set a new price target of $3.11
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)
Q2 2024 Overview Net revenue of $1.52 billion decreased 0.5 percent year over year Comparable sales increased 0.3 percent year over year and increased 3.5 percent on a two-year basis GAAP net loss of $24.8 million, or $(0.09) per share, compared to GAAP net loss of $14.6 million, or $(0.05) per share in the prior yearAdjusted EBITDA1 of $83.5 million compared to $112.6 million in the prior yearOperating Cash Flow of $69.4 million compared to $96.6 million in the prior yearFree Cash Flow 1 of $42.0 million compared to $44.6 million in the prior yearSAN DIEGO, Sept. 10, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), a complete partner in pet health and wellness, to
SAN DIEGO, Aug. 1, 2024 /PRNewswire/ -- On September 10, 2024, at approximately 4:00 p.m. Eastern, Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, will release its second quarter 2024 earnings results. Additionally, Petco executives will host a conference call at approximately 5:00 p.m. Eastern to review the company's financial and operating performance. The call will be webcast live and the earnings release and earnings presentation will be available on the company's Investor Relations page at ir.petco.com. A replay of th
Q1 2024 Overview Net revenue of $1.5 billion decreased 1.7 percent year over year Comparable sales declined 1.2 percent year over year and increased 4.1 percent on a two-year basis GAAP net loss of $46.5 million, or $(0.17) per share, compared to GAAP net loss of $1.9 million, or $(0.01) per share in the prior yearAdjusted Net Income1 of $(11.8) million, or $(0.04) per share, compared to $14.9 million, or $0.06 per share in the prior yearAdjusted EBITDA1 of $75.6 million compared to $111.0 million in the prior yearOperating Cash Flow of $(8.4) million compared to $37.7 million in the prior yearFree Cash Flow 1 of $(41.1) million compared to $(24.4) million in the prior yearSAN DIEGO, May 22,
10-Q - Petco Health & Wellness Company, Inc. (0001826470) (Filer)
8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)
8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)
Citigroup analyst Steven Zaccone maintains Petco Health and Wellness (NASDAQ:WOOF) with a Neutral and raises the price target from $3 to $4.
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Petco Health and Wellness (NASDAQ:WOOF) in the last three months. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 2 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 3 1 0 0 3M Ago 0 0 1 0 0 Analysts have recently evaluated Petco Health and Wellness and provided 12-month price targets. The average target is $3.71, accompanied by a high estimate of $5.00 and a low estimate of $
Wedbush analyst Seth Basham maintains Petco Health and Wellness (NASDAQ:WOOF) with a Outperform and raises the price target from $4 to $5.
SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)
SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)
SC 13G - Petco Health & Wellness Company, Inc. (0001826470) (Subject)